CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

A visual look at Wall Street's Santa Claus rallies since 2000, even as such a rally comes under pressure on Thursday. Read ...

AliExpress International and South Korea-based E-Mart's e-commerce platform Gmarket are forming a 50-50 joint venture in ...

Nokian grew underlying earnings regardless prior to the rapid production ramp-up. Its Romanian factory will start production ...

Trainline is capitalizing on the digitization of rail travel with a 17% sales increase. See why we recommend a buy rating on ...

Green Dot is poised for growth with strong FCF yield and market positions, but faces risks from retail declines and customer ...

Green Brick's Q3 2024 revenues were $523 million, which is a 25.7% increase YoY. It offers the possibility of buying a solid ...

Melco Resorts' Q324 shows improvement. Substantial debt and upcoming maturities pose significant financial risks. Read an ...

TFLO is a top choice for reliable income investing, offering stability and above-average yields in uncertain market ...

Read here for an analysis of Intuitive Surgical (ISRG) stock's growth and valuation, highlighting potential risks and future ...

Dropbox has had a nice run, but the honeymoon period of people defaulting into their premium tier appears to be over. Read ...

Leggett & Platt's vertical integration and restructuring plans are expected to enhance operating margins and free cash flow ...